3rd Quarter - Termination Amendment — FABIANI & COMPANY for AFRAXIS (2010)

Firm

FABIANI & COMPANY

Client

AFRAXIS

Income

—

Expenses

—

Terminated

Aug 31, 2010

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
3rd Quarter - Termination	Oct 19, 2010	—	Replaced
3rd Quarter - Termination Amendment (this page)	Jan 20, 2011	—	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); SENATE; Natl Institutes of Health (NIH); Natl Institute of Mental Health (NIMH)

Pharmacy PHA

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Natl Institute of Mental Health (NIMH); Defense, Dept of (DOD)

Medical/Disease Research/Clinical Labs MED

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Centers For Disease Control & Prevention (CDC); Natl Institute of Mental Health (NIMH); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.